IFNB1 and neoplasm: Adipose tissue-derived stem cells (ASCs) overexpressing either IFN-β or TRAIL (ASC-IFN-β or ASC-TRAIL, respectively) have been reported to inhibit tumor growth in a xenograft model [26,27].